Displaying publications 1 - 20 of 123 in total

Abstract:
Sort:
  1. Chen WT, Wang CW, Lu CW, Chen CB, Lee HE, Hung SI, et al.
    J Invest Dermatol, 2018 07;138(7):1546-1554.
    PMID: 29458119 DOI: 10.1016/j.jid.2018.02.004
    Dapsone-induced hypersensitivity reactions may cause severe cutaneous adverse reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS). It has been reported that HLA-B*13:01 is strongly associated with dapsone-induced hypersensitivity reactions among leprosy patients. However, the phenotype specificity and detailed immune mechanism of HLA-B*13:01 remain unclear. We investigated the genetic predisposition, HLA-B*13:01 function, and cytotoxic T cells involved in the pathogenesis of dapsone-induced severe cutaneous adverse reactions. We enrolled patients from Taiwan and Malaysia with DRESS and maculopapular eruption with chronic inflammatory dermatoses. Our results showed that the HLA-B*13:01 allele was present in 85.7% (6/7) of patients with dapsone DRESS (odds ratio = 49.64, 95% confidence interval = 5.89-418.13; corrected P = 2.92 × 10-4) but in only 10.8% (73/677) of general population control individuals in Taiwan. The level of granulysin, the severe cutaneous adverse reaction-specific cytotoxic protein released from cytotoxic T cells, was increased in both the plasma of DRESS patients (36.14 ± 9.02 ng/ml, P < 0.05) and in vitro lymphocyte activation test (71.4%, 5/7 patients) compared with healthy control individuals. Furthermore, dapsone-specific cytotoxic T cells were significantly activated when co-cultured with HLA-B*13:01-expressing antigen presenting cells in the presence of dapsone (3.9-fold increase, compared with cells with no HLA-B*13:01 expression; P < 0.01). This study indicates that HLA-B*13:01 is strongly associated with dapsone DRESS and describes a functional role for the HLA-restricted immune mechanism induced by dapsone.
    Matched MeSH terms: Leprosy/drug therapy*
  2. Yusuf SYM, Ismail IA, Hamid RA, Jamil NA, Yasin MM
    Open Access Maced J Med Sci, 2019 Jun 15;7(11):1815-1817.
    PMID: 31316665 DOI: 10.3889/oamjms.2019.481
    BACKGROUND: Leprosy or Hansen disease is a chronic infectious disease that causes social stigma due to its deforming bodily appearance and physical disability. It has a wide spectrum of presentation affecting diagnosis.

    CASE REPORT: A 21-year-old man who presented with chronic isolated bilateral pinna swelling as a result of leprosy is reported. The bilateral pinna swelling started as multiple shiny papules with an erythematous background and progressively became hyperpigmented and lobular over two years. This rare presentation of leprosy poses initial diagnostic difficulties, leading to misdiagnoses by various health care professionals. Diagnoses ascribed include eczema, insect bite and perichondritis. A suspicion of leprosy was raised when hyperaesthetic hypopigmentation of skin started to appear on the body after two years, with worsening of the pinna swellings. This was confirmed by identification of Mycobacterium leprae in slit skin smear test and skin biopsy.

    CONCLUSION: Isolated involvement of pinna in a patient without lesions in other body parts is an unusual initial presentation of leprosy. However, leprosy should be kept as a rare differential diagnosis of isolated lesions on the ear in patients not responding to conventional treatment.

    Matched MeSH terms: Leprosy
  3. Kwan Z, Wong SM, Robinson S, Tan LL, Ismail R
    Australas J Dermatol, 2017 Nov;58(4):e267-e268.
    PMID: 28660702 DOI: 10.1111/ajd.12541
    Matched MeSH terms: Leprosy/epidemiology
  4. Silva JF
    Paraplegia, 1973 Aug;11(2):146-58.
    PMID: 4584434 DOI: 10.1038/sc.1973.19
    One hundred and forty-one patients with non-traumatic paraplegia were reviewed. The common causative factors and the problems arising were evaluated. Management of the clinical problems were described. The need for prevention and early treatment has been stressed.
    Matched MeSH terms: Leprosy/complications
  5. Mohamed KB
    PMID: 11480315
    Matched MeSH terms: Leprosy/diagnosis*
  6. Pearson JMH, Pettit JHS, Rees RJ
    PMID: 4877115
    Proof that a patient is suffering from sulfone-resistant leprosy depends on demonstrating that his bacilli can multiply in the mouse foot pad even when the mice are fed sulfone in the diet. Hitherto the maximal dose of DDS tolerated by the mouse has been used in such tests. This paper concerns a patient whose bacilli multiplied in mice fed lower doses of DDS, but were inhibited when the maximal dose was used . His clinical features are distinctive and probably characteristic of this type of "partial" resistance. It is likely that more cases of this type will be found . Recommendations are made concerning the investigation of possible DDS-resistant leprosy patients and their treatment.
    Matched MeSH terms: Leprosy/drug therapy*
  7. Bolton JM
    Br Med J, 1968 Jun 29;2(5608):818-23.
    PMID: 5658921
    Matched MeSH terms: Leprosy/prevention & control
  8. Nur Asheila Abdul Taib, Razitasham Safii
    Borneo Epidemiology Journal, 2020;1(1):16-34.
    MyJurnal
    According to the World Health Organization (WHO), rabies is one of the 18 neglected tropical diseases, together with dengue, leprosy, and trachoma, among others. Despite being a vaccine-preventable disease, the latest estimate of annual human rabies mortality from a 2015 study is as high as 59,000 throughout 150 countries. In human rabies, more than 95% of the cases are due to dog bites, making the elimination of canine rabies a global priority by fighting the disease at its animal source. World Health Organization (WHO), World Organization for Animal Health (OIE), Food and Agriculture Organization (FAO) of the United Nations, and the Global Alliance for Rabies Control (GARC) have warranted the One Health framework with the objective of complete eradication of dog-related human rabies by the year 2030. In an effort to rationalise the One Health approach, this scoping review found 17 studies on assessing the effectiveness of control interventions of human and canine rabies. Different strategies were implemented based on the endemicity of rabies in a particular country. Overall, the combined strategies using the One Health approach, which allows effectiveparticipation and communication between different agencies, have shown promising results in reducing rabies cases. These strategies will hopefully realise the goal in the Global Strategic Plan to achieve zero canine-mediated human rabies death by the year2030.
    Matched MeSH terms: Leprosy
  9. Tang ASO, Yeo ST, Teh YC, Kho WM, Chew LP, Muniandy P
    Oxf Med Case Reports, 2019 Jan;2019(1):omy111.
    PMID: 30697428 DOI: 10.1093/omcr/omy111
    Limited data regarding methemoglobinemia in pregnancy, particularly secondary to dapsone is available up to date. We report a case of dapsone-induced methemoglobinemia in a pregnant mother with multibacillary leprosy who presented with fever, productive cough and cyanosis of 2 days duration 2 weeks after multidrug therapy was commenced. On examination, she had central cyanosis with low oxygen saturation (SpO2 = 84-88%). Arterial blood gas analysis showed PO2 of 111 mmHg and SO2 of 98 mmHg. Patient was administered 100% oxygen inhalation, but there was no improvement in cyanosis. Vitamin C (1000 mg/day) was prescribed. Dapsone was replaced by ofloxacin 200 mg twice daily. There was a gradual increase in SpO2 level. She delivered a healthy baby. In conclusion, clinicians should be aware of the side effects of dapsone and know how to promptly manage any undesirable events. Ofloxacin is a safe and feasible alternative in replacement of dapsone in pregnancy.
    Matched MeSH terms: Leprosy, Multibacillary
  10. Jamil A, Noor NM, Osman AS, Baseri MM, Muthupalaniappen L
    Indian J Dermatol Venereol Leprol, 2013 Jul-Aug;79(4):527-9.
    PMID: 23760326 DOI: 10.4103/0378-6323.113096
    Matched MeSH terms: Leprosy/drug therapy*; Leprosy/epidemiology*
  11. Hobbs HE
    PMID: 4677492
    Matched MeSH terms: Leprosy/complications*; Leprosy/therapy
  12. Sahoo MR, Dhanabal SP, Jadhav AN, Reddy V, Muguli G, Babu UV, et al.
    J Ethnopharmacol, 2014 May 28;154(1):17-25.
    PMID: 24732111 DOI: 10.1016/j.jep.2014.03.029
    The genus Hydnocarpus (Flacourtiaceae) includes forty species that are spread across the globe. In the Indian System of Medicine, Hydnocarpus pentandrus (Buch.-Ham.) Oken. is primarily used for treating leprosy and other skin disorders. It is known as "Chaulmoogra" and is also used to treat other indications including constipation, inflammation, blood disorders, and worm infestations. Various species of Hydnocarpus are also used in traditional medicine in China, Thailand, Malaysia, and Myanmar for several skin disorders. To assess the therapeutic potential of species from the Hydnocarpus genus and to determine future avenues for research.
    Matched MeSH terms: Leprosy/drug therapy
  13. Singh M
    Med J Malaysia, 1985 Jun;40(2):139-41.
    PMID: 3841732
    A case of rare retinal lesion occurring in a young girl suffering from lepromatous leprosy is described. Fundus lesions in leprosy are extremely rare but do occur in some cases without causing any threat to vision. Their response to antileprotic treatment is not clearly known.
    Matched MeSH terms: Leprosy/complications*
  14. Mohamed KN
    Lepr Rev, 1984 Dec;55(4):385-9.
    PMID: 6527602
    Matched MeSH terms: Leprosy/drug therapy*
  15. Jayalakshmi
    Malays J Pathol, 1980 Aug;3:39-45.
    PMID: 7186596
    Matched MeSH terms: Leprosy/pathology*
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links